Wikipedia -WSS

Wikipedia

author：entertainment 2025-10-02 07:05:44 - browse：8114

Immunofluorescence image shows CD4+ (green) and CD8+ (yellow) T cells in the microenvironment of a head and neck squamous cell carcinoma. — This immunofluorescence image shows T cells (in green and yellow) in the microenvironment of a head and neck squamous cell carcinoma. Allen Lab/NCI/NIH

Merus said Tuesday that the combination of its experimental drug petosemtamab with the checkpoint inhibitor Keytruda shrank tumors in 62% of patients with head and neck cancer, according to an interim analysis of an ongoing mid-stage clinical trial.

The new efficacy results, derived from a larger number of patients, look similar to an initial disclosure made last week that triggered a 36% increase in Merus’ stock price.

But the Dutch drugmaker on Tuesday withheld additional information from the study related to the safety and durability of petosemtamab’s tumor responses, pending presentation at the annual meeting of the American Society of Clinical Oncology on June 3.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： There's an unseen cost to disruptive road

leisure time

focus

WSS

TikTok, Instagram influencers need more rules for drug ads

FDA sets aggressive timeline for overhauling inspection procedures

Medicare bonuses could stop drug shortages under Senate plan

After John Oliver segment, STAT readers share their opioid

Target recalls 2.2 million additional candles due to laceration, burn hazards

FDA endorses new sterilization method for medical devices

Wikipedia

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

Guidelines to prevent youth baseball injuries need more muscle

Some of the ways extreme heat will change life as we know it

Apple is now the first public company to be valued at $3 trillion

TB outbreak tied to bone grafts underscores testing shortcomings

DIEP, the 'gold standard' of breast reconstruction, is under threat

White House drug shortages task force keeps mum with Congress

23andMe had bad news about my health. I wish a person had delivered it

CVS is on a mission to consolidate health care. Will it work?

State Dept. review finds Biden bears some blame for Afghanistan failures

Genentech weighs delaying cancer therapy after drug pricing law

focus

TikTok, Instagram influencers need more rules for drug ads

High breast density mammograms need follow

Large hospital system sues Multiplan for low

Pharma budget tightening trickles down to Doximity

Where are patients getting their prescriptions for GLP

Dog Aging Project founders on what lies ahead after losing funding

leisure time

explore

focus

leisure time